thymoquinone has been researched along with Insulin Resistance in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosseinzadeh, H; Kaviani, F; Mohsenzadeh, MS; Rameshrad, M; Razavi, BM | 1 |
| Datta, K; Kumar, S; Saha, P; Tyagi, RK | 1 |
| Dinda, AK; Gupta, YK; Maulik, SK; Prabhakar, P; Reeta, KH | 1 |
| Abd Al Haleem, EN; Awad, AS; El-Bakly, WM; Sherief, MA | 1 |
| Heuberger, AL; Kester, AC; Reddivari, L; Vanamala, J | 1 |
1 review(s) available for thymoquinone and Insulin Resistance
| Article | Year |
|---|---|
Mitigation of obesity-promoted diseases by Nigella sativa and thymoquinone.
Topics: Antioxidants; Benzoquinones; Cardiovascular Diseases; Chemoradiotherapy, Adjuvant; Humans; Insulin Resistance; Neoplasms; Nigella sativa; Obesity; Plant Extracts; Weight Loss | 2012 |
4 other study(ies) available for thymoquinone and Insulin Resistance
| Article | Year |
|---|---|
Thymoquinone attenuates olanzapine-induced metabolic disorders in rats.
Topics: AMP-Activated Protein Kinases; Animals; Benzoquinones; Glucose; Insulin Resistance; Leptin; Obesity; Olanzapine; Rats; Rats, Wistar | 2023 |
Upsurge in autophagy, associated with mifepristone-treated polycystic ovarian condition, is reversed upon thymoquinone treatment.
Topics: Androgens; Animals; Autophagy; Beclin-1; Benzoquinones; Disease Models, Animal; eIF-2 Kinase; Female; Gene Expression Regulation; Granulosa Cells; Humans; Insulin Resistance; Mifepristone; Ovary; Ovulation; Polycystic Ovary Syndrome; Rats; Receptors, Androgen | 2021 |
Protective effect of thymoquinone against high-fructose diet-induced metabolic syndrome in rats.
Topics: Animals; Benzoquinones; Catalase; Cholesterol, HDL; Cholesterol, LDL; Disease Models, Animal; Dose-Response Relationship, Drug; Fructose; Glucose Tolerance Test; Glutathione; Hyperglycemia; Insulin Resistance; Liver; Male; Metabolic Syndrome; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Triglycerides | 2015 |
Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Diet, High-Fat; Hepatitis; Inflammation Mediators; Insulin Resistance; Interleukin-10; Lipids; Liver; Liver Cirrhosis, Experimental; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Tumor Necrosis Factor-alpha | 2016 |